Trial Profile
Switching to sirolimus versus continuing tacrolimus in renal transplant recipients
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 24 Jul 2012
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 04 May 2011 Preliminary results presented at the American Transplant Congress -- 11th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.
- 05 Nov 2010 New trial record.